Effects of a modified yeast supplement on cold/flu symptoms.
Urol Nurs
; 28(1): 50-5, 2008 Feb.
Article
en En
| MEDLINE
| ID: mdl-18335698
ABSTRACT
A yeast-based product (EpiCor, a dried Saccharomyces cerevisiae fermentate) was compared to placebo to determine effects on the incidence and duration of cold and flu-like symptoms in healthy subjects recently vaccinated for seasonal influenza. In a 12-week, randomized, double-blind, placebo-controlled clinical trial, 116 participants received daily supplementation with 500 mg of EpiCor or placebo for 12 weeks. Data collected included periodic in-clinic examinations and serologic evaluations at baseline, 6- and 12-weeks. Subjects also utilized a standardized self-report symptom diary during the study. Participants receiving the yeast-based product had significantly fewer symptoms and significantly shorter duration of symptoms when compared with subjects taking a placebo.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Levadura Seca
/
Resfriado Común
/
Suplementos Dietéticos
/
Gripe Humana
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Incidence_studies
/
Prognostic_studies
Límite:
Adolescent
/
Adult
/
Aged
/
Humans
/
Middle aged
Idioma:
En
Año:
2008
Tipo del documento:
Article